Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Crohn'S & Colitis
|
April 22, 2015
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course
S Paul, G Boschetti, M Rinaudo-Gaujous, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2016
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
B Ungar, U Kopylov, T Engel, et al.
United European Gastroenterology Journal
|
March 25, 2026
Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease
X Roblin, S Nancey, K Papamichael, et al.
Journal of Crohn'S & Colitis
|
February 26, 2022
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study
C Cottron, X Treton, R Altwegg, et al.
Digestive Diseases and Sciences
|
May 30, 2021
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis
L Servais, G Boschetti, C Meunier, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
P Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis
|
February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
G Pineton de Chambrun, B Pariente, P Seksik, et al.
Journal of Crohn'S & Colitis
|
September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]
J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Crohn'S & Colitis
|
April 22, 2015
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course
S Paul, G Boschetti, M Rinaudo-Gaujous, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2016
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
B Ungar, U Kopylov, T Engel, et al.
United European Gastroenterology Journal
|
March 25, 2026
Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease
X Roblin, S Nancey, K Papamichael, et al.
Journal of Crohn'S & Colitis
|
February 26, 2022
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study
C Cottron, X Treton, R Altwegg, et al.
Digestive Diseases and Sciences
|
May 30, 2021
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis
L Servais, G Boschetti, C Meunier, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
P Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis
|
February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
G Pineton de Chambrun, B Pariente, P Seksik, et al.
Journal of Crohn'S & Colitis
|
September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]
J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Page
of 9